How is antibiotic-loaded bone cement adoption growing as a primary TJA infection prevention strategy?
Periprosthetic joint infection (PJI) following total hip and knee arthroplasty represents one of the most devastating post-surgical complications — requiring two-stage revision surgery at total costs exceeding USD 100,000 per episode — creating compelling cost-effectiveness rationale for prophylactic antibiotic delivery through bone cement at primary arthroplasty. Gentamicin-loaded and tobramycin-loaded PMMA bone cement achieves local antibiotic concentrations at the prosthesis-bone interface orders of magnitude above systemic antibiotic serum levels, providing targeted prophylaxis against gram-negative organisms at concentrations unachievable through intravenous prophylaxis alone. Published meta-analyses of ALBC versus plain cement in TKA report statistically significant reduction in deep infection rates sustaining growing ALBC adoption recommendations in high-risk patient populations.

What viscosity characteristics distinguish high-viscosity bone cement from low and medium viscosity variants?
High-viscosity PMMA bone cements — formulated through modification of powder-to-liquid ratio and polymer chain length to achieve a high-viscosity working phase within 30 to 90 seconds of mixing — can be inserted into the femoral canal or acetabular socket immediately after mixing without a low-viscosity liquid phase during which cement runs off the application site. This rapid viscosity development reduces bone cement vapour exposure time for the operating room team, enables cement gun application without a waiting period, and reduces the risk of fat embolism associated with hydraulic pressure generated during canal pressurisation with flowing low-viscosity cement. High-viscosity cement adoption has grown particularly in cemented femoral stem total hip arthroplasty where consistent canal fill and interlocking with cancellous bone is critical for long-term fixation.

What is sustaining vertebroplasty and kyphoplasty procedure volumes and bone cement demand?
Osteoporotic vertebral compression fractures — affecting approximately 1.5 million Americans and disproportionately impacting postmenopausal women and elderly men with secondary osteoporosis — generate acute vertebral pain and progressive kyphotic deformity that substantially impairs quality of life and functional independence. Balloon kyphoplasty, which restores partial vertebral height by expanding a tamp balloon within the fractured vertebral body prior to cement injection, generates durable pain relief in the majority of appropriately selected acute fracture patients and sustains per-procedure bone cement consumption of 4 to 8 mL per vertebral level. U.S. CMS reimbursement coverage for kyphoplasty and vertebroplasty sustains procedural volume independent of arthroplasty cement market dynamics.

How does calcium phosphate cement sustain demand in non-arthroplasty orthopaedic applications?
Calcium phosphate bone cements — which set into hydroxyapatite-like crystalline structures and are gradually resorbed and replaced by new bone during healing — are preferred over PMMA in cortical defect filling and metaphyseal fracture void management applications where PMMA’s permanent non-resorbable character and exothermic polymerisation would impair biological healing or cause thermal necrosis of adjacent cancellous bone. Calcaneus fractures, distal radius fractures with metaphyseal void, and tibial plateau fractures with joint impaction are established indications for calcium phosphate bone cement void filling that sustains demand for resorbable cement alternatives to PMMA in trauma and fracture surgery.

How is bone cement delivery system evolution improving clinical application efficiency?
Closed vacuum mixing systems that polymerise PMMA bone cement under vacuum conditions reduce atmospheric monomer vapour exposure for operating room personnel above open bowl mixing technique, and reduce cement porosity from trapped air bubbles that weakens cement mechanical properties. Prefilled bone cement guns with temperature-controlled storage maintaining optimal viscosity ranges at the point of use, and ready-to-use dual-syringe antibiotic bone cement systems eliminating intraoperative powder-liquid mixing steps, are sustaining above-standard-cement premium pricing for packaged delivery system convenience and occupational safety compliance.

Which bone cement segments are growing fastest?
Antibiotic-loaded bone cement adoption in high-risk TJA as primary infection prevention, high-viscosity PMMA formulations reducing operative vapour exposure and canal pressurisation complications, kyphoplasty bone cement demand sustained by vertebral augmentation procedure volume, and calcium phosphate resorbable cement adoption in metaphyseal fracture void filling are the four fastest-growing segments.